Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.060
-0.020 (-1.85%)
At close: Apr 1, 2025, 4:00 PM
1.080
+0.019 (1.84%)
After-hours: Apr 1, 2025, 4:37 PM EDT
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,525,333
Market Cap
115.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TLSA News
- 7 days ago - Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial - GlobeNewsWire
- 15 days ago - Tiziana Life Sciences to Present at the 37th Annual Roth Conference - GlobeNewsWire
- 18 days ago - Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury - GlobeNewsWire
- 5 weeks ago - Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter - GlobeNewsWire
- 5 weeks ago - Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC - GlobeNewsWire
- 6 weeks ago - Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program - GlobeNewsWire